• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microorganisms . SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

tetano

Editor, Senior Moderator
Microorganisms


. 2021 Mar 4;9(3):525.
doi: 10.3390/microorganisms9030525.
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention


Alessio Danilo Inchingolo[SUP] 1 [/SUP], Angelo Michele Inchingolo[SUP] 1 [/SUP], Ioana Roxana Bordea[SUP] 2 [/SUP], Giuseppina Malcangi[SUP] 1 [/SUP], Edit Xhajanka[SUP] 3 [/SUP], Antonio Scarano[SUP] 4 [/SUP], Felice Lorusso[SUP] 4 [/SUP], Marco Farronato[SUP] 5 [/SUP], Gianluca Martino Tartaglia[SUP] 5 [/SUP], Ciro Gargiulo Isacco[SUP] 1 6 7 [/SUP], Grazia Marinelli[SUP] 1 [/SUP], Maria Teresa D'Oria[SUP] 1 8 [/SUP], Denisa Hazballa[SUP] 1 9 [/SUP], Luigi Santacroce[SUP] 1 [/SUP], Andrea Ballini[SUP] 10 11 [/SUP], Maria Contaldo[SUP] 12 [/SUP], Francesco Inchingolo[SUP] 1 [/SUP], Gianna Dipalma[SUP] 1 [/SUP]



Affiliations

Abstract

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a multi-drug pharmacological approach. The purpose of this investigation was to evaluate through a literature overview the effect of adjuvant therapies and supplements for the SARS-CoV-2 infection. The research has analyzed the advantage of the EK1C4, by also assessing the studies on the resveratrol, vitamin D, and melatonin as adjuvant supplements for long hauler patients' prognosis. The evaluated substances reported important benefits for the improvement of the immune system and as a potential inhibitor molecules against SARS-CoV-2, highlighting the use of sartans as therapy. The adjuvant supplements seem to create an advantage for the healing of the long hauler patients affected by chronic symptoms of constant chest and heart pain, intestinal disorders, headache, difficulty concentrating, memory loss, and tachycardia.

Keywords: COVID-19; SARS-CoV-2; cytokine storm syndrome; endovir stop spray; furin; microbiome; oral mucosa; pandemics; resveratrol; vaccines.
 
Back
Top Bottom